The updated indications reflect the recognition that Stelfonta may be used in any case where surgery may not be an option:
For the treatment of non-metastatic (WHO staging) mast cell tumours that are either non-resectable or those that are resectable but where surgery is not considered the best option, specifically: cutaneous mast cell tumours (located anywhere on the dog) and subcutaneous mast cell tumours located at or distal to the elbow or the hock.
Tumours must be less than or equal to 8 cm 3 in volume, and must be accessible to intratumoral injection.
Neil Mottram MRCVS, Technical Manager at Virbac said: “Stelfonta offers veterinary surgeons a medical option for the successful elimination of mast cell tumours.
"The extended labelled indication demonstrates the wide variety of cases that can benefit where medical treatment is preferred, such as; tumour factors (location and size) making surgical margins difficult, patient factors (concurrent disease and risk of anaesthesia), clinic factors and the simplification of this medical treatment and owner factors, where there is a preference to avoid surgery."
Stelfonta is administered by injection directly into the tumour mass and Virbac say that generally, dogs do not require sedation or local or general anaesthesia during treatment.
The active ingredient, Tigilanol tiglate, works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
www.virbac.co.uk
Designed to help veterinary teams make clearer, more confident clinical decisions, the flowchart provides a step-by-step approach to diagnosing and managing ear disease in dogs and cats.
Renzo Di Florio, Technical Veterinary Adviser at Krka UK, said: “It takes you through each step, from diagnosis to treatment and long-term management, including identifying cases that might benefit from referral.
"It can also help practices to develop an otitis externa management plan protocol that’s useful for the whole team, and that’s practical and easy to integrate into existing workflows.”
One of the main messages in the flowchart is the central role of cytology in otitis management.
Tim said: “Cytology is essential to assess the level of inflammation and detect the presence of bacteria or Malassezia.
"This helps clinicians make informed decisions about whether antibiotics are truly needed.
"In contrast, culture and sensitivity testing can be misleading when used to guide topical therapy.”
https://www.krka.co.uk/veterinary-knowledge-hub
The Investigating Committee and the Disciplinary Committee are responsible for conducting desk-top investigations and disciplinary hearings in response to complaints, disclosures and notifications that may amount to serious professional misconduct by Registered Farriers.
As the Royal College of Veterinary Surgeons did in 2015, the FRC is splitting off its disciplinary functions from that of its Council, meaning it now needs to recruit new members to perform the role.
More information is available in VetSurgeon Jobs, here.
The charity is asking everyone to donate £5 and nominate 5 friends to get involved in the activities.
The activities are:
For more information, visit: https://www.vetlife.org.uk
Vetlife Helpline is available 24 hours a day, 365 days a year on: 0303 040 2551 or via anonymous email at https://helpline.vetlife.org.uk
The factsheets, which cover canine chronic bronchitis, feline asthma and equine asthma, are designed to help explain complex conditions more effectively, encourage earlier diagnosis, and improve treatment compliance.
The downloadable factsheets can be printed, emailed to clients, or displayed in waiting areas and on waiting room screens.
Jon Slattery MRCVS, Director of BreathEazy, said: “We often see a seasonal spike in respiratory cases at this time of year, particularly in animals with underlying conditions.
"Having owners on board and confident in managing their pet’s condition is a key part of treatment success.
"These factsheets offer a time-saving way for vets and nurses to educate clients, reinforce advice given in consults, and help owners understand how to support their pets at home.”
https://mailchi.mp/breatheazy/resourcedownload
www.breatheazy.co.uk
The study1 investigated the effects of a weight loss programme on biochemical and immunological profile, blood leptin level, and cardiovascular parameters in a cohort of dogs with naturally occurring obesity, in order to address the effects due to the imbalance of these aspects on the clinical presentation and management of canine obesity.
For the study, eleven obese but otherwise healthy dogs were included in a six-month weight loss programme, together with a control group of eleven healthy dogs at ideal body condition.
After the six-month weight loss programme, the obese dogs showed clinical improvements on a number of key indicators related to immune function, such as reduced tumour necrosis factor (TNF)-α and interleukin (IL)-6, known to impair insulin action in metabolic tissues but also favour cancer development in humans. Ten out of eleven showing a reduced BCS and no longer classified as obese.
Ten out of eleven dog owners also reported that their dogs were more active and that their quality of life had notably improved.
Hugues du Plessis, Pet Obesity Prevention Manager, at Purina said: “Preventing pet obesity is a major focus at Purina. We not only want to be providing pet owners with information on the benefits of a healthy pet lifestyle, but we also want to help them achieve it. This is why we are working with partner organisations to understand how behavioural science can be used to support owners, from the recognition of an issue, to the changes that will make a difference".
Reference:
The Blue Cross is offering a lifeline to even more needy pets across the UK following an extension to its successful veterinary grant scheme.
Relaunched as “The Blue Cross Veterinary Care Fund”, the charity has increased available funding and doubled the maximum grant it will pay towards veterinary costs of a particular treatment, operation or neutering procedure if the owner can't afford it.
The initiative was first launched in 2005 to help pet owners on low incomes who do not live near Blue Cross hospitals or clinics. So far the charity has awarded thousands of grants through 1,100 veterinary practices, 28% of all private vets in the UK. The demand from needy pets around the country prompted The Blue Cross to increase the maximum grant to £200 towards the veterinary treatment costs.
Pet owners must be on a means tested benefit or state pension with no other income to be eligible for support through the Veterinary Care Fund. Those on a very low income may also be eligible for the grant and should contact The Blue Cross for further advice.
The charity is also opening a new veterinary welfare clinic on 3 June 2008. The clinic, based at the animal adoption centre in Tiverton, will carry out basic procedures such as microchipping and vaccinations, and treat minor ailments. More serious or complicated cases will be referred to a local veterinary practice where treatment will be subsidised by The Blue Cross.
For more information about the Veterinary Care Fund or how clients can apply please contact The Blue Cross customer care team on 01993 825593 or email info@bluecross.org.uk
Bayer Animal Health has re-designed Drontal Cat and Drontal Cat XL tablets from a round shape to a smaller ellipsoid one, in order to make worming an easier process.
Bayer's Drontal brand manager Dan White said: "Market research conducted among 218 cat owners in August revealed that an ellipsoid, smaller tablet was preferred. In fact, 69% of non-Drontal Cat users indicated they would prefer to switch from their current worming product to an ellipsoid, smaller tablet. So we have re-designed the shape of the tablet across the Drontal Cat range.
"Drontal is the only wormer that kills every type of gastrointestinal worm commonly found in UK cats. So it was not surprising the research also showed Drontal to have the highest brand awareness, at 37%, of all cat worming products."
The new Drontal Cat Ellipsoid tablets are now available, and in new pack sizes of 2, 24 and 96. For large cats, Drontal Cat XL Ellipsoid has new pack sizes of 2, 8, and 48, and these packs will be available in early 2011.
For more information about the new Drontal Cat tablets, please contact your Bayer territory manager.
The practice has assembled a team of post-graduate certificate holding veterinary surgeons, supporting specialists, nurses and front-of-house staff to offer a comprehensive range of services, including advanced orthopaedic and soft tissue surgery and outpatient diagnostic imaging.
In order to make its service more accessible, the practice has also developed a number of innovative aspects to its service, including a 'fixed price fix', a guaranteed 'same week solution' and an interest-free credit payment option.
Lead veterinary surgeon Ross Allan (pictured right) said: "We consider the launch of Roundhouse Referrals to be one of the most exciting developments in the provision of advanced veterinary services to clients in the West of Scotland for many years.
"While there are existing referral options, we want to remove some of the current challenges that prevent vets and pet owners from accessing these services.
"We all know how frustrating waiting lists can be for vets and their clients, and by creating the 'same week solution' we pledge to arrange an appointment and provide a referral consultation within one week, something we feel will be reassuring to referring vets and clients.
"In addition, we are delighted to improve provision for pet owners with financial restrictions such as low value or no insurance policies. Roundhouse Referrals has been established to address these concerns through the provision of a high quality, highly accessible service and 'same week solution' for referring veterinary practices, and through such services as our 'fixed price fix' and interest free credit.
"Similarly, we are committed to the principle of an easy-to-use service for referring vet and client: price certainty, the personal touch and great communication."
Roundhouse Referrals says it can undertake an extensive range of investigative and surgical orthopaedic procedures including: fracture repair; lameness investigation; growth deformities; arthrodesis; arthroscopic surgery and ligament or tendon injury. Its soft tissue services include: endocrine surgery; ENT; gastrointestinal; hernia surgery; oncological; thoracic; urogenital; vascular; wound management and reconstructive surgeries.
The practice also says it undertakes to work in partnership with referring veterinary practices to provide an easier referral system that will always return satisfied clients to the referring practice.
For further information, contact 0141 649 1316 or visit: www.rhr.vet
The webinar will be presented by Marge Chandler DVM, MS, MANZCVS, DACVIM (SAIM, Nutrition), MRCVS and Dr Michael Lappin DVM, PhD, DACVIM.
Marge is an independent consultant in small animal nutrition and internal medicine and Chair of the FEDIAF Scientific Advisory Committee, founding member of the European Veterinary Nutrition Educators Group, and Co-Chair of the WSAVA Global Nutrition Committee.
Michael is the Kenneth W. Smith Professor in Small Animal Clinical Veterinary Medicine and Director of the Center for Companion Animal Studies at Colorado State University. He is on the editorial board of Feline Medicine and Surgery and Compendium on Continuing Education for the Practicing Veterinarian and is the editor of the textbook, Feline Internal Medicine Secrets.
The webinar will discuss the value supplements can offer to pets who are already on complete diets, how supplements are regulated and the importance of quality control.
The session will also cover the challenges for vets in selecting supplements for their clinical practice, what factors can determine the choice of supplement, and how you can critically evaluate the evidence supporting a supplement.
Marge and Michael will also provide tips for communicating the benefits of supplements to clients.
Daniel Rodes Moltó of the Purina Institute said: “We are pleased to offer this interactive webinar on how to evaluate and select supplements using an evidence-based approach in a non-promotional setting.
"Webinar attendees are welcome to submit questions for our speakers in advance and to ask questions during the live event, which promises to be an enjoyable and lively session supporting the aim of improving the lives of pets.”
https://webapp.spotme.com/login/eventspace/CollaborativeCareMay2023
Addison’s disease is caused by a reduction in corticosteroid secretion from the adrenal glands. Symptoms can include lack of appetite, tremors or vomiting, diarrhoea, lethargy, low heart rate, muscle weakness, low body temperature and collapse. If left untreated, Addison’s disease can present as an acute, life-threatening emergency.
Zycortal is the only European licensed treatment for the disease. It is a prolonged-release suspension used as replacement therapy for mineralocorticoid. Dechra says it has proved highly effective in clinical trials with more than 80% of dogs responding positively to treatment1.
The golden rules are available at: www.dechra.co.uk/goldenrules.
Dechra has also produced a series of six video presentations to help veterinary surgeons in their diagnosis and treatment and created a dedicated owner website - www.myaddisonsdog.co.uk - to help owners understand the condition and monitor their pet's progress.
Dechra Brand Manager Craig Sankey said: "Addison’s can be a hidden disease but Zycortal presents a very visible answer. With the wealth of expertise from the endocrinologists, the Five Golden Rules should be an important reference tool for vets.
"We hope that the series of resources we have produced, used in partnership with Zycortal, will make the diagnosis, treatment and management of dogs with Addison’s an easier journey for both vets and owner."
Reference
The new changes are being introduced in the following phases:
The new Environmental Sustainability Award allows practices to demonstrate that they have embedded environmentally sustainable behaviours and are excelling with their sustainability goals.
The Award includes points for reducing waste, consolidating medicines orders and minimising drug wastage, and calculating the practice’s carbon footprint and setting reduction targets.
The changes and additions to the standards at Core Standards and General Practice level cover the sustainability of a wide range of practice areas, including requiring a sustainability policy, communicating sustainability achievements, and minimising anaesthetic gas usage.
As well as improving environmental sustainability, the new and amended standards also include requirements to help make practices more socially sustainable, through measures including increasing diversity and inclusion.
The PSS has produced a list of resources to support veterinary practices with meeting the new environmental sustainability standards and implementing sustainable practices in general.
Mandisa Greene, Chair of the Practice Standards Group, said: “We want to assure PSS-accredited practices that the new standards won’t mean an overhaul of ways of working or result in expensive investment in resources.
"Instead, the standards explain ways that practices can increase their sustainability by putting in place new measures gradually over the next 12 months, in time for them becoming mandatory.
"As with all standards updates, the PSS team are always available to answer any questions that practices have and anyone who is unsure about how to apply them is encouraged to get in touch with the PSS team.”
During the last Standards Committee meeting, there were also several approved clarifications to the standards in the form of guidance notes and minor changes across a range of accreditation levels.
These include updates to the guidance notes for requirements on sterilisation of dental instruments, environmental swabbing of clinical areas, and anaesthetic monitoring.
The new version of the standards that includes all the latest changes, and a separate document listing all the updates, are available to download here: https://www.rcvs.org.uk/setting-standards/practice-standards-scheme/additional-resources
Any questions from practices about the updates can be sent to the PSS team at pss@rcvs.org.uk
Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage 2.
The new diet delivers the same therapeutic dosage as benazepril tablets (0.5–1 mg/kg bodyweight/day).
Nutrition-wise, Vikaly is low phosphorus (0.5% as fed), has reduced protein (30% as fed), contains omega-3 fatty acids (1.2%, including 0.6% EPA & DHA) and offers high metabolisable energy (416 kcal/100g).
Virbac highlights data showing that CKD remains the leading cause of mortality in cats over five years old and affects up to 40% of feline patients over the age of ten1,2.
The company says administering daily treatment is recognised as a major issue for CKD cat owners with 45% of owners not administering treatment daily as they should and 51% of owners citing administration difficulties as the reason why3.
This new product eliminates the need to administer medication separately, which could completely transform treatment compliance, removing the risk of missed doses and reducing stress for both cats and their owners.
Virbac says that due to the pharmacokinetic profile of benazepril, which is incorporated into the kibble, at an equivalent dose Vikaly displays greater ACE inhibition than benazepril tablets4.
The rate of food consumption also does not affect plasma Benazeprilat levels, ensuring consistent treatment efficacy regardless of the cat’s feeding behaviour5.
Virbac says that in practice, this means that even if the cat being treated consumes less than 50% of their daily ration, efficacy is maintained with ACE activity similar to that of benazepril tablets.
Benazepril has a wide therapeutic margin, tolerated to 20x the minimum effective dose (10mg/kg) for 52 weeks, with the first signs of toxicity being reduced erythrocytes counts & ovary/oviduct weights6.
Virbac says that with Vikaly, these levels cannot be reached because the active ingredient is contained in food, which would require a cat to consume more than 10 times their daily ration.
Vikaly is presented in a 1.5kg bag, which equates to a 30 day supply for a 4.5kg cat with normal bodyweight.
It can be fed alongside wet food, providing that the cat consumes at least 50% of their daily ration before being given the wet food.
The daily ration can also be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and to promote consistent food intake.
Vikaly is a prescription diet.
References
Jason (pictured right with Paul), said: "Let me tell you, that was hard! Nine days and 900km of mountain bike riding, with 250km technical single track and only about 10 km tar, but we did it! We are so proud to be able to contribute to a future for rhinos!"
The veterinary velocipedists were raising money for The Chipembere Foundation, which specialises in sourcing, testing and funding technology for monitoring rhinos. They fund K9 handlers and their tracking and apprehension dogs, as well as funding and providing anti-poaching teams with vital equipment needed to translocate rhinos across Southern Africa.
It costs about £38000 to translocate a rhino from South Africa to neighbouring Botswana where there is less poaching (for now). Satellite tracking leg collars cost £1500 with an annual service and VHF collars and transmitters costing around £220. Dog and dog handler training is in the region of around £5000 per dog and there are additional costs for kennels, transport vehicles and day to day items like bowls, brushes, leads etc.
If you want to support Jason and Paul in their efforts to make a positive difference to the plight of the fast-dwindling numbers of rhino, visit www.justgiving.com/teams/rhinocycle.
Dr Sabela Atencia DVM MVM Dip-ECVIM CA MRCVS is an internal medicine specialist who holds the European Diploma in Small Animal Internal Medicine.
During her research for her Masters degree on muscular dystrophy in the Japanese Spitz breed, she contributed to knowledge of the underlying mutation of the disease, facilitating the development of a genetic test.
Sabela enjoys all aspects of canine and feline Internal Medicine, but is particularly interested in endoscopy, endocrinology and genetics.
Dr Owen Davies MA VetMB MVetMed MANZCVS(SAM) MRCVS, a veterinary medical oncology clinician, holds a Masters degree based on research into canine lymphoma.
Owen is interested in all aspects of medical oncology, especially haematopoietic malignancies, targeted therapy for cancer and paraneoplastic disease. He has recently completed a residency in veterinary oncology at the Royal Veterinary College and has just passed the DACVIM examinations in Oncology.
Dr Elisabetta Mancinelli DVM CertZooMed Dipl ECZM (Small Mammal) MRCVS is a European Veterinary Specialist in Zoological Medicine (Small Mammal Medicine and Surgery) and an RCVS Recognised Specialist in Zoo and Wildlife Medicine.
She was the first veterinary surgeon to undertake the European College of Zoological Medicine (ECZM) Residency in Small Mammal Medicine, which she completed at The Royal (Dick) School of Veterinary Studies, Edinburgh.
Elisabetta will lead and further expand the established exotic pet service at the Hospital.
Acting Hospital Director, Professor Stuart Carmichael said: "As we continue to extend the range of services and expertise we offer to our clients, we are delighted to welcome these three distinguished professionals to the team here at Highcroft. They will make a great contribution and it’s great to have them aboard."
Highcroft Veterinary Referrals is based at 615 Wells Road, Whitchurch, Bristol and can be contacted on 01275 832410.
Photo: Left to right: Dr Elisabetta Mancinelli, Dr Owen Davies, Dr Sabela Atencia
For the study, researchers from the RVC’s VetCompass Programme identified 2,105 hypothyroidism cases diagnosed amongst a study population of 905,553 UK dogs.
This revealed an annual frequency of one case in 400 dogs (0.23%) for the condition, with the most common breeds diagnosed being Standard Doberman Pinschers (x 17.02), Tibetan Terriers (x11.25), Boxers (x10.44) and Alaskan Malamutes (x 9.71).
The average age at first diagnosis was 7.65 years.
Other findings included:
Dr Rebecca Geddes, Lecturer in Small Animal Internal Medicine at the RVC Queen Mother Hospital for Animals and last author of the paper, said: “It is great to have this data from UK primary care practices, which will help highlight high risk breeds to veterinary surgeons so they can diagnose and treat affected dogs as early as possible. Hypothyroidism is usually straightforward to manage with medication that can greatly improve quality of life in affected dogs.”
Vetigel is a plant based gel which was first introduced to the UK for orthodontic surgeries last year.
It is supplied in a pre-filled syringe and applied directly to the site of bleeding where it creates an initial mechanical seal and then supports the formation of the platelet plug below.
VetPlus says it can be used in many situations where bleeding is an issue and the gel can be applied directly to the site of bleeding, including liver biopsies, mass removals, amputations and enucleations.
Jackie Marshall, VetPlus Technical Advisor, said: “This innovative product is already transforming the way vets perform both dental and surgical procedures, and we have had really positive feedback from those practices where it is being used already.
"Vetigel isn’t intended to replace a surgeon’s technique, but it is designed to stop bleeding where pressure or other methods are ineffective or impractical.
"Because it is a gel, it can conform to a wide range of wound shapes, making it a rapid, effective way of controlling bleeding.
“We believe this product will make a lasting impact on veterinary care, transforming the way surgeries are carried out and assisting haemostasis in animal patients.”
Zak Leavold, a vet based at Calster Vets in Great Yarmouth used Vetigel in an emergency situation, out of hours, on a dog with a bleed due to a kidney laceration.
He said: ‘I genuinely believe the product saved the dog’s life that night.
"I will certainly be keeping Vetigel on hand for any future soft surgeries – just in case!’
Links
At first glance, one might ask why? After all, who - other than the pilot - would fly with Thomas Cook sober?
However, there's a world of difference between being not entirely sober and Ms Heyes's level of intoxication, which according to the judge at Greater Manchester Magistrates Court, made her 'every passenger's worst nightmare', and earned her a sentence of 80 hours community service, a victim surcharge of £80 and £250 in costs.
At the start of her disciplinary hearing, Ms Heyes admitted the facts of her 2020 conviction, but denied that the conviction rendered her unfit to practise as a veterinary nurse.
The Committee then considered whether Ms Heyes's conduct amounted to serious professional misconduct.
The Disciplinary Guidance states: “A conviction may be related to professional or personal behaviour and whether it renders a respondent unfit to practise is a matter of judgment for the Disciplinary Committee.
"Behaviour unconnected with the practice of veterinary surgery can cause concerns about the protection of animals or the wider public interest.”
The Committee concluded that the conviction and underlying behaviour was sufficiently serious that it required a finding that Ms Heyes was unfit to practise veterinary nursing on public interest grounds and that it also breached Code 6.5 of the Code of Professional Conduct for Veterinary Nurses which states: ‘Veterinary nurses must not engage in any activity or behaviour that would be likely to bring the profession into disrepute or undermine public confidence in the profession’.
The Committee then considered the most appropriate sanction for Ms Heyes, taking into account the relevant aggravating and mitigating factors.
Aggravating factors included the risk Ms Heyes caused to passengers, including children and that she had behaved recklessly, falling far below the standard to be expected of a member of the veterinary nursing profession.
In mitigation, the Committee considered this was a single and isolated incident, Ms Heyes had no previous disciplinary findings against her and following her conviction she had shown developing insight.
It also noted that she had continued to practise as a competent and dedicated veterinary nurse.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee decided to reprimand Ms Heyes because of its finding that the charge amounted to disgraceful conduct and rendered Ms Heyes unfit to practise.
"Such a sanction was necessary in the Committee’s view because the conviction brought the profession into disrepute.
"Whilst the charge was not so serious as to require suspension or removal from the register, the Committee decided it is necessary to issue a formal warning to Ms Heyes as to her future conduct.
“Taking into account the overall circumstances of the case including the positive references and the fact that a number of mitigating factors set out in the Disciplinary Committee Sanctions Guidance were present in this case, the Committee was satisfied that this sanction would meet the public interest and protect the reputation of the profession and uphold standards within the profession; thereby maintaining public confidence in the College as the regulator for veterinary nurses.”
The full details of the hearing and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary
Anthony Chadwick, a referral dermatologist, has teamed up with other experts to offer a series of web-based seminars with the aim of bringing accessible and convenient CPD to vets. 50 VetSurgeon members can attend the webinars for half price. Just enter the word vetsurgeon in the discount box on the site.
The webinars can be viewed from a practice or office and cover key veterinary topics including:
The webinars will be broadcast between 9.00 pm and 10.00 pm in a series running from 22 April to 27 May 2010.
Anthony said: "Many vets don't finish consulting until 7.00 pm and then have evening or family commitments. This can make finding the time to attend high quality CPD difficult, particularly if it's a long way away.
"Webinars are already proving popular as a convenient but effective form of CPD in many sectors so I'm hoping to help the veterinary profession share the benefits they offer. Certainly my own experience is that they are easy to access and offer excellent value without the hassle of travel and late nights."
To view the webinars vets need a fixed line broadband connection, a PC with a sound card and a headset. Once payment is made, delegates are given instructions online to enable them to view the webinar they have selected.
The cost to view the whole series is £80.
Further information, including the full course schedule, is available at http://www.thewebinarvet.com/ or by contacting Anthony Chadwick on 0151 270 1759.
CVS has announced the acquisition of four further veterinary practices bringing the total number of practices it owns across the UK to 92 operating from 253 sites.
The latest practices to join CVS are: Crescent Veterinary Clinic Ltd, Melton Mowbray; Miller & Swann Veterinary Surgery, Elgin; West Mount Vets, Halifax and Anchorage Veterinary Hospital, Acle.
CVS now employs more than 2,300 staff at its veterinary practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, two pet crematoriums and six veterinary laboratories.
Matthew, who holds a European Certificate in Small Animal Surgery, is one of a small group of veterinary dentists in the UK. He has a special interest in the endodontic (root canal) treatment of teeth.
Ray Girotti, Hospital Director at Lumbry Park, said: "The increasing prevalence of oral and dental disease among dogs and cats and its potential to cause significant pain and infection, not just in the oral cavity but within the whole body, highlights the importance of advanced dental care.
"We are delighted to be working with Matthew. He will be accepting referrals for a range of dental problems, including fractured teeth, root canal treatment, prosthetic crowns, fractured jaws, oral tumours and orthodontics.
"In leading our dental referral service, he will work alongside our specialist teams in cardiology, internal medicine, orthopaedics, neurology, diagnostic imaging and anaesthesia to ensure that we are providing a full service and comprehensive approach to the care of our patients."
Matthew added: "I’m excited to be launching a new dental referral service at Lumbry Park. The advanced facilities it offers, including the capability to work with specialist anaesthetists and to utilise the latest in-house 3D CT and MRI imaging equipment, make it a fantastic opportunity and I’m looking forward to working closely with my colleagues to deliver an outstanding dental referral service."
The Horse Trust provides a range of services to support working horses, while Medical Detection Dogs trains dogs to alert their owners to cancers and other medical conditions, providing pre-emptive non-invasive warning.
Stephen said: "These two charities' work in strengthening and supporting the human-animal bond is truly remarkable. Though The Horse Trust was originally founded in 1886 as a retirement home for working horses, and this remains a core focus of theirs to this day, it has now evolved to provide a whole range of services, from education to research to rescuing neglected equids.
"Medical Detection Dogs, though founded much more recently in 2008, has already done an incredible amount in its short history - 76 of its dogs are now partnered with people with critical medical conditions, ensuring essential emotional as well as medical support."
Jeanette Allen, CEO of The Horse Trust, said: "The Horse Trust is extremely grateful to the RCVS for this enormously generous donation. We care for 130 horses, ponies and donkeys that have either retired from public service or been rescued from appalling conditions. We also provide dedicated training programmes for first responders who have to deal with horses in crisis situations, as well as being the second largest funder of equine specific veterinary research in the UK. We survive as a charity on donations, and this one is most welcome and greatly appreciated."
Claire Guest, co-founder and chief executive of Medical Detection Dogs, said: "We are so grateful to the RCVS for their very generous donation. We receive no government funding for our work, so we rely entirely on the generosity of organisations like the RCVS. Thanks to this donation, we can continue our pioneering research into the detection of human disease using the extraordinary smelling power of dogs."
The President’s Christmas Box donation is made every year in lieu of sending out RCVS Christmas cards. Previous recipients have included Worldwide Veterinary Service, Mind, Riding for the Disabled Association, Canine Partners, Hounds for Heroes, and Vetlife.
The company points out that poisoning cases rise dramatically over Christmas, when food that is poisonous to dogs is more likely to be left out and owners are more relaxed (is that a euphemism, TVM?).
For that reason, the Emedog bumper pack contains 20 x 1ml single use vials - four times more than the regular pack and retails at £251.76 a saving of 10% compared to purchasing four regular packs.
Dosage is one vial injected subcutaneously per 10kg and vials have a three-year unopened shelf life, which should minise wastage.
Will Peel MRCVS, Product Manager at TVM UK said: "The number of poisoned animals seen by vets rises dramatically over the festive season so it’s vital that vets have enough product to see them through this time. The Emedog bumper pack will ensure that they are prepared for Christmas with the resources they need to deal with such cases."
The Emedog bumper pack is available from November 2019 from all veterinary wholesalers.
The RSPCA is asking veterinary surgeons to take part in a new survey which aims to build a true picture of the scale of the problem of illegally imported puppies being brought into the UK.
Amongst other things, the survey asks what you consider to be the greatest concerns regarding the poor breeding, dealing and illegal import of puppies and what you think can be done to tackle these and the associated problems.
You can take part in the survey here: www.surveymonkey.com/s/QQNBVFV
James Yeates, Chief Veterinary Officer, said: "RSPCA intelligence suggests that there is a growing illegal trade in puppies from other EU countries and is causing serious health and welfare problems. In many cases puppies are dying or becoming seriously ill. Risk factors appear to include being taken from their mothers too early, not being vaccinated and having to endure long journeys in poor conditions.
"However, it's very difficult to get a full view on the scale of the problem as many cases never get reported to the RSPCA. Vets are likely to be the first port of call when a puppy bought by an unsuspecting buyer becomes sick and may be faced with many of these cases - if sadly not all.
"We're interested in hearing from vets to get their evidence from practice and to hear their ideas about how we can tackle the lucrative illegal trade in puppies."
Rexxolide contains 100 mg/ml of tulathromycin, which is widely used to treat BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, to make it more convenient.
Dechra says Rexxolide has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis.
Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.
"We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition."
Rexxolide is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.